NewsBenzingaStifel维持对Stryker的买入评级，将目标价下调至330美元 Stifel维持对Stryker的买入评级，将目标价下调至330美元 Benzinga 2026.09.30 12:43 (GMT+0) Open on Benzinga Other news Micron Earnings Prediction Market Preview: Can the AI Memory Boom Keep Running? Wells Fargo Maintains Equal-Weight on First Horizon, Lowers Price Target to $25 Tirzepatide or Semaglutide? Novo Nordisk Says Higher Semaglutide Dose Shows Cardiovascular Edge Over Eli Lilly's Tirzepatide (CORRECTED) Iovance Biotherapeutics Stock Pauses After Hitting New 52-Week High: What's Going On? Wells Fargo Maintains Overweight on First BanCorp, Lowers Price Target to $32 Wells Fargo Maintains Overweight on F N B, Lowers Price Target to $21
Tirzepatide or Semaglutide? Novo Nordisk Says Higher Semaglutide Dose Shows Cardiovascular Edge Over Eli Lilly's Tirzepatide (CORRECTED)
